Objective: Shivering is a frequent and undesirable complication of cesarean section with spinal anesthesia. The present study aimed to determine the effects of ketamine on the levels of cytokines, immunoglobulins and brain-derived neurotrophic factor (BDNF) during cesarean section-mediated perioperative shivering. Methods: In this randomized controlled trial, eighty patients undergoing cesarean section were enrolled. They were randomly allocated to one of two groups: a control group (n = 40) that received normal saline, and a ketamine group (n = 40) that received ketamine at a dose of 0.25 mg/kg. Maternal blood samples were collected at three predefined time points: after study drug administration (T1), after umbilical cord clamping (T2), and at the end of surgery (T3). Results: At the T2 time point, the ketamine group exhibited a significant reduction in maternal cytokine concentrations compared to the saline control. Umbilical cord immunoglobulin concentrations were comparable between groups. Moreover, no correlation was found between umbilical cord BDNF and maternal cytokine levels at T2. Conclusions: Ketamine alleviated cesarean section-mediated perioperative shivering via diminishing cytokines, without impacting the levels of BDNF or immunoglobulins. Moreover, ketamine treatment decreased the levels of cytokines in the maternal blood; thus, abrogating the risk of transferal into the neonate.
| Published in | American Journal of Clinical and Experimental Medicine (Volume 13, Issue 6) |
| DOI | 10.11648/j.ajcem.20251306.14 |
| Page(s) | 184-192 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2025. Published by Science Publishing Group |
BDNF, Cytokines, Ketamine, Shivering, Umbilical Blood
| [1] | Denizli M, Capitano ML, Kua KL. Maternal obesity and the impact of associated early-life inflammation on long-term health of offspring [J]. Front Cell Infect Microbiol. 2022; 12: 940937. |
| [2] | Jennen L, De Weerdt L, Kouriannidi E, et al. Cytokine Levels in Mother-infant Pairs at Term and Preterm Delivery [J]. Pediatr Infect Dis J. 2025; 44(2S): S61-S65. |
| [3] | Uram-Benka A, Fabri-Galambos I, Pandurov-Brlić M, et al. Optimizing Newborn Outcomes in Cesarean Sections: A Comparative Analysis of Stress Indicators under General and Spinal Anesthesia [J]. Children (Basel). 2024; 11(7): 783. |
| [4] | Aggarwal R, Jain AK, Mittal P, et al. Association of pro- and anti-inflammatory cytokines in preeclampsia [J]. J Clin Lab Anal. 2019; 33(4): e22834. |
| [5] | Treviño-Garza C, Villarreal-Martínez L, Estrada-Zúñiga CM, et al. Leptin, IL-6 and TNF-α levels in umbilical cord blood of healthy term newborns in relation to mode of delivery [J]. J Obstet Gynaecol. 2016; 36(6): 719-721. |
| [6] | Yockey LJ, Iwasaki A. Interferons and Proinflammatory Cytokines in Pregnancy and Fetal Development [J]. Immunity. 2018; 49(3): 397-412. |
| [7] | De Berardis D, Tomasetti C, Pompili M, et al. An Update on Glutamatergic System in Suicidal Depression and on the Role of Esketamine [J]. Curr Top Med Chem. 2020; 20(7): 554-584. |
| [8] | Zhang K, Yao Y, Hashimoto K. Ketamine and its metabolites: Potential as novel treatments for depression [J]. Neuropharmacology. 2023; 222: 109305. |
| [9] | Nowak W, Grendas LN, Sanmarco LM, et al. Pro-inflammatory monocyte profile in patients with major depressive disorder and suicide behaviour and how ketamine induces anti-inflammatory M2 macrophages by NMDAR and mTOR [J]. EBioMedicine. 2019; 50: 290-305. |
| [10] | Ferrea G, Monks DT, Singh PM, et al. Comparative efficacy of intravenous treatments for perioperative shivering in patients undergoing caesarean delivery under neuraxial anaesthesia: A systematic review and Bayesian network meta-analysis of randomised-controlled trials [J]. J Clin Anesth. 2025; 100: 111680. |
| [11] | Yu G, Jin S, Chen J, et al. The effects of novel α2-adrenoreceptor agonist dexmedetomidine on shivering in patients underwent caesarean section [J]. Biosci Rep. 2019; 39 (2): BSR20181847. |
| [12] | Kumar K, Lin C, Symons T, et al. Narrative Review on Perioperative Shivering during Caesarean Section under Neuraxial Anaesthesia [J]. Rom J Anaesth Intensive Care. 2023; 29(1): 41-46. |
| [13] | Aboelsuod MAA, Elnaggar AMA, Alwafa TAAA, et al. Effect of Intravenous Ketamine Infusion on Hemodynamics of Patients Undergoing Cesarean Delivery after Spinal Anaesthesia: A Randomized, Double-Blind, Controlled Trial [J]. Turk J Anaesthesiol Reanim. 2023; 51(5): 420-426. |
| [14] | Liu J, Wang Y, Ma W. Shivering prevention and treatment during cesarean delivery under neuraxial anesthesia: a systematic review [J]. Minerva Anestesiol. 2018; 84(12): 1393-1405. |
| [15] | Mohammadzadeh Jouryabi A, Sharami SH, Mansour Ghanaie M, et al. Comparing the Effects of Low Dose of Ketamine, Tramadol, and Ondansetron in Prevention of Post Spinal Anesthesia Shivering in Cesarean Section [J]. Anesth Pain Med. 2021; 11(4): e116429. |
| [16] | Hopewell S, Chan AW, Collins GS, et al. CONSORT 2025 statement: updated guideline for reporting randomised trials [J]. BMJ. 2025; 389: e081123. |
| [17] | Jayaraj A, Balachander H, Kuppusamy SK, et al. Comparison of meperidine, tramadol and fentanyl for post-spinal shivering prevention during cesarean delivery: A double-blind randomized controlled trial [J]. J Obstet Gynaecol Res. 2019; 45(11): 2202-2208. |
| [18] | Kose EA, Honca M, Dal D, et al. Prophylactic ketamine to prevent shivering in parturients undergoing Cesarean delivery during spinal anesthesia [J]. J Clin Anesth. 2013; 25(4): 275-280. |
| [19] | Rhind SG, Castellani JW, Brenner IK, et al. Intracellular monocyte and serum cytokine expression is modulated by exhausting exercise and cold exposure [J]. Am J Physiol Regul Integr Comp Physiol. 2001; 281(1): R66-R75. |
| [20] | Barbic D, Andolfatto G, Grunau B, et al. Rapid Agitation Control With Ketamine in the Emergency Department: A Blinded, Randomized Controlled Trial [J]. Ann Emerg Med. 2021; 78(6): 788-795. |
| [21] | Agrawal P, Singh P, Singh KP. Vilazodone exposure during pregnancy: Effects on embryo-fetal development, pregnancy outcomes and fetal neurotoxicity by BDNF/Bax-Bcl2/5-HT mediated mechanisms [J]. Neurotoxicology. 2024; 105: 280-292. |
| [22] | Zawadzka A, Cieślik M, Adamczyk A. The Role of Maternal Immune Activation in the Pathogenesis of Autism: A Review of the Evidence, Proposed Mechanisms and Implications for Treatment [J]. Int J Mol Sci. 2021; 22(21): 11516. Published 2021 Oct 26. |
| [23] | Lubrano C, Parisi F, Cetin I. Impact of Maternal Environment and Inflammation on Fetal Neurodevelopment [J]. Antioxidants (Basel). 2024; 13(4): 453. |
| [24] | Yavi M, Lee H, Henter ID, Park LT, Zarate CA Jr. Ketamine treatment for depression: a review [J]. Discov Ment Health. 2022; 2(1): 9. |
APA Style
Yu, Z., Liu, Y., Huang, Z., Pan, D. (2025). Effects of Ketamine on the Profile of Cytokines and Bdnf in Maternal and Umbilical Cord Blood During Cesarean Delivery. American Journal of Clinical and Experimental Medicine, 13(6), 184-192. https://doi.org/10.11648/j.ajcem.20251306.14
ACS Style
Yu, Z.; Liu, Y.; Huang, Z.; Pan, D. Effects of Ketamine on the Profile of Cytokines and Bdnf in Maternal and Umbilical Cord Blood During Cesarean Delivery. Am. J. Clin. Exp. Med. 2025, 13(6), 184-192. doi: 10.11648/j.ajcem.20251306.14
@article{10.11648/j.ajcem.20251306.14,
author = {Zhi-yang Yu and Yang Liu and Zu-chao Huang and Dong-ge Pan},
title = {Effects of Ketamine on the Profile of Cytokines and Bdnf in Maternal and Umbilical Cord Blood During Cesarean Delivery},
journal = {American Journal of Clinical and Experimental Medicine},
volume = {13},
number = {6},
pages = {184-192},
doi = {10.11648/j.ajcem.20251306.14},
url = {https://doi.org/10.11648/j.ajcem.20251306.14},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajcem.20251306.14},
abstract = {Objective: Shivering is a frequent and undesirable complication of cesarean section with spinal anesthesia. The present study aimed to determine the effects of ketamine on the levels of cytokines, immunoglobulins and brain-derived neurotrophic factor (BDNF) during cesarean section-mediated perioperative shivering. Methods: In this randomized controlled trial, eighty patients undergoing cesarean section were enrolled. They were randomly allocated to one of two groups: a control group (n = 40) that received normal saline, and a ketamine group (n = 40) that received ketamine at a dose of 0.25 mg/kg. Maternal blood samples were collected at three predefined time points: after study drug administration (T1), after umbilical cord clamping (T2), and at the end of surgery (T3). Results: At the T2 time point, the ketamine group exhibited a significant reduction in maternal cytokine concentrations compared to the saline control. Umbilical cord immunoglobulin concentrations were comparable between groups. Moreover, no correlation was found between umbilical cord BDNF and maternal cytokine levels at T2. Conclusions: Ketamine alleviated cesarean section-mediated perioperative shivering via diminishing cytokines, without impacting the levels of BDNF or immunoglobulins. Moreover, ketamine treatment decreased the levels of cytokines in the maternal blood; thus, abrogating the risk of transferal into the neonate.},
year = {2025}
}
TY - JOUR T1 - Effects of Ketamine on the Profile of Cytokines and Bdnf in Maternal and Umbilical Cord Blood During Cesarean Delivery AU - Zhi-yang Yu AU - Yang Liu AU - Zu-chao Huang AU - Dong-ge Pan Y1 - 2025/12/29 PY - 2025 N1 - https://doi.org/10.11648/j.ajcem.20251306.14 DO - 10.11648/j.ajcem.20251306.14 T2 - American Journal of Clinical and Experimental Medicine JF - American Journal of Clinical and Experimental Medicine JO - American Journal of Clinical and Experimental Medicine SP - 184 EP - 192 PB - Science Publishing Group SN - 2330-8133 UR - https://doi.org/10.11648/j.ajcem.20251306.14 AB - Objective: Shivering is a frequent and undesirable complication of cesarean section with spinal anesthesia. The present study aimed to determine the effects of ketamine on the levels of cytokines, immunoglobulins and brain-derived neurotrophic factor (BDNF) during cesarean section-mediated perioperative shivering. Methods: In this randomized controlled trial, eighty patients undergoing cesarean section were enrolled. They were randomly allocated to one of two groups: a control group (n = 40) that received normal saline, and a ketamine group (n = 40) that received ketamine at a dose of 0.25 mg/kg. Maternal blood samples were collected at three predefined time points: after study drug administration (T1), after umbilical cord clamping (T2), and at the end of surgery (T3). Results: At the T2 time point, the ketamine group exhibited a significant reduction in maternal cytokine concentrations compared to the saline control. Umbilical cord immunoglobulin concentrations were comparable between groups. Moreover, no correlation was found between umbilical cord BDNF and maternal cytokine levels at T2. Conclusions: Ketamine alleviated cesarean section-mediated perioperative shivering via diminishing cytokines, without impacting the levels of BDNF or immunoglobulins. Moreover, ketamine treatment decreased the levels of cytokines in the maternal blood; thus, abrogating the risk of transferal into the neonate. VL - 13 IS - 6 ER -